A new fluorometnc assay for determining dipeptidyl peptidase IV (DPP IV; EC 3.4.14.5) was developed. The synthetic substrate glycyl-L-proline-4-methoxy-2-naphthylamide (20 mmol/L), Tris buffer (50 mmol/L, pH 8.3), and serum (20 JLL) are mixed and incubated. The reaction is stopped with citrate (100 mmol/L, pH 4.0) and the released 4-methoxy-2-naphthylamrne is measured fluorometrically. The mean value of DPP IV activity in serum for 64 healthy subjects was 58 (SD 16) j.tmol of 4-methoxy-2-naphthylamine released per liter of serum per minute. The proposed procedure is sensitive, rapid, and accurate and can easily be automated.
(1). The penultimate residue must be Pro, Hyp, or Ala, with Pro showing the greatest rate. The N-terminal position may be occupied by several residues. DPP N cleaves not only substance P, a potent inflammatory mediator (2, 3), but also casomorphin-5. Recently, some authors evaluated the role of DPP Win the metabolism of physiologically important peptides (4, 5). Observations that DPP N activity is altered in various pathological conditions (6-10) generated the need for an accurate, clinically applicable assay. Here we describe a fluorometric method for determining DPP N activity in human serum. DPP IV catalyzes the cleavage of the fluorogenic substrate, Gly-Pro-4-Me-2-NA, releasing the highly fluorescent 4-Me-2-NA, which can be measured directly. The method is simple, fast, specific, and highly sensitive. It can be automated for routine clinical use.
Materials and Methods

Materials
Serum samples. Blood sampled from 64 blood-bankdonors (ages 18-65 y) was allowed to clot at room temperature, centrifuged (2000 x g, 15 mm), and the serum was removed and stored at -70 #{176}C until assayed.
Reagents. 
Instruments.
We measured fluorescence with a Model RF-5000 fluorometer (Shimadzu Corp., Tokyo 160, Japan), with a quartz cuvet (optical path length 0.5 cm). A TE-7 Ternpette water bath (Tecam, Cambridge, U.K.) was used for incubations (37 #{176}C ± 0.1 #{176}C). For a colorimetric assay we used a Cobas-Bio centrifugal analyzer (Roche Diagnostic Systems, Montclair, NJ).
Substrate solution.
Gly-Pro-4-Me-2-NA, 20 mmol/L, in DMSO. Dissolve 7.37 mg of substrate in 1 mL of DMSO; store at 4 #{176}C. This solution is stable for at least one month.
Incubation buffer. Ti-is HC1, 50 mmoIJL, pH 8.3. Make pH adjustments at room temperature. 
Results
Optimum Conditions for Enzyme Assay
Dependence of DPP IV activity on pH. We investigated the pH dependence of DPP N activity in Tris HC1 (pta = 8.3), 50 mmol/L, at various pH values (from 6.7 to 9.5). DPP N exhibits its highest activity over the pH range 8.1-8.9. (Figure 1) . pH determinations were made at room temperature.
Determination of Michaelis-Menten constant. DPP IV activity was determined by assaying with substrate concentrations ranging from 0.2 to 350 unol/L. We calculated Im, Sensitivity. We determined the sensitivity of the method by measuring DPP N activity in diluted serum samples, with the assay conditions mentioned above. We could measure DPP LV activities as low as 5.0 U/L. By prolonging the incubation, lower activities can be detected.
Precision. Within-assay precision was evaluated by analyzing 10 replicate samples of serum in duplicate in a single run. We used three samples with low, medium, and high 10 DPP N activity. Between-assay precision was calculated after analyzing aliquots of these three samples in 10 differ-5 ent runs over two weeks (Table 1 (Figure 2) . For routine enzyme assay, we used a substrate concentration of 1.5 mmol/L to ensure zero-order kinetics.
Linearity. Substrate hydrolysis showed a linear relationship with time, up to 2 h. We incubated aliquots of the same sample for various intervals (x in mm) ranging from 10 to 120 miii, and we calculated the total amount (nmol) of product formed (y) during the incubation. The line of best-fit is given by the equation y = 4.151x + 2.288. Linear regression analysis of these data yielded an r value of 0.9992. We suggest an incubation time of 20 miii for determining DPP in serum, assuring readily measurable values within an acceptable time interval. The assay allows measurement of serum samples with an activity up to at least 300 U/L. To study linearity as a function of serum dilution, we made serial dilutions (in isotonic saline) up to 10 times of a serum sample with an average DPP N activity and analyzed it as described. We calculated the total amount (nmol) of product formed (y) during 20 mm. The linear regression line is defined by the equation y = 9.145x + 0.04 (r = 0.996), where x represents the dilution factor from 0.1 to 1. This proves the reliability of the method over a wide concentration range. No interferences could be stated in lipemic sera or in samples from patients with jaundice. 
DiscussIon
Several methods have been described for determining DPP N activity in serum. In most, synthetic substrates that are derivatives of the Gly-Pro dipeptide are used, which provide good affinity and specificity (11). In some methods, colorimetry is used to measure the release of 2-naphthylamine after diazotization. This multi-step method results in lower values for DPP N activity (22.6 ± 0.9 UIL) (12). The proposed fluorometric procedure assures specificity, precision, and sensitivity. Additional advantages of the method are convenience and economy of time and materials, making it easy to screen large numbers of serum samples. The method correlates well with the colorimetric assay. With the same chromogenic substrate as in that study (11), Fijita et al. (13) obtained a mean value of 55 ± 13 UIL (n = 53), very similar to the mean activity we found with the fluorometric method (58 ± 16 UIL). The increasing interest and probable diagnostic usefulness of DPP N activity in serum justifies the development of an alternative assay. Significantly higher DPP IV activity was found in serum of patients with hepatobiliary diseases (6). Patients with gastric or pancreatic cancer showed significantly subnormal enzyme activity (9) . The increased DPP N activity in hyperthyroidism may also be of interest, and its cause is to be investigated (14). 
